Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
49.02
+0.56 (1.16%)
Jun 12, 2025, 4:00 PM - Market closed
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 12 professional analysts, the 12-month price target for Mirum Pharmaceuticals stock ranges from a low of $39 to a high of $77. The average analyst price target of $63.17 forecasts a 28.87% increase in the stock price over the next year.
Price Target: $63.17 (+28.87%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 5 | 5 |
| Buy | 8 | 7 | 7 | 7 | 7 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 11 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $73 | Strong Buy | Initiates | $73 | +48.92% | May 19, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $73 → $77 | Strong Buy | Maintains | $73 → $77 | +57.08% | May 13, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $74 → $76 | Buy | Maintains | $74 → $76 | +55.04% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $66 → $72 | Strong Buy | Maintains | $66 → $72 | +46.88% | Feb 28, 2025 |
| Baird | Baird | Buy Maintains $50 → $55 | Buy | Maintains | $50 → $55 | +12.20% | Feb 27, 2025 |
Financial Forecast
Revenue This Year
457.60M
from 336.89M
Increased by 35.83%
Revenue Next Year
534.61M
from 457.60M
Increased by 16.83%
EPS This Year
-0.98
from -1.85
EPS Next Year
-0.57
from -0.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 478.4M | 597.0M | 711.3M | ||
| Avg | 457.6M | 534.6M | 638.3M | ||
| Low | 433.3M | 473.4M | 565.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 42.0% | 30.5% | 33.1% | ||
| Avg | 35.8% | 16.8% | 19.4% | ||
| Low | 28.6% | 3.5% | 5.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.01 | 0.03 | 0.88 | ||
| Avg | -0.98 | -0.57 | 0.55 | ||
| Low | -1.47 | -1.59 | -0.23 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.